Clinical Trial Update: Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating radiation therapy with or without optional tamoxifen for treating ductal carcinoma in situ in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED